Home › Funds › Exor N.V. › NMRA
Exor N.V. position in NMRA
NEUMORA THERAPEUTICS INC. · Health Care
Exor N.V. reported holding 4,215,662 shares of NMRA (NEUMORA THERAPEUTICS INC.) in its Q3 2026 13F filing — a position valued at US$2.5M, representing 0.01% of its reported portfolio and ranking #7 among its reported holdings. Exor N.V. has disclosed NMRA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Exor N.V.'s NMRA position evolved
Exor N.V. first disclosed a stake in NMRA in Q3 2023 at 4,215,662 shares (US$59.5M). The position peaked in Q4 2023 at 4,215,662 shares, worth US$71.9M. Across 13 filings, Exor N.V. held the position steady without any share-count change. The most recent filing (Q3 2026) shows 4,215,662 shares valued at US$2.5M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 4.22M | $59.48M | New |
| Q4 2023 | 4.22M | $71.88M | Hold |
| Q1 2024 | 4.22M | $57.97M | Hold |
| Q2 2024 | 4.22M | $41.44M | Hold |
| Q3 2024 | 4.22M | $55.69M | Hold |
| Q4 2024 | 4.22M | $44.69M | Hold |
| Q1 2025 | 4.22M | $4.22M | Hold |
| Q2 2025 | 4.22M | $3.09M | Hold |
| Q3 2025 | 4.22M | $7.67M | Hold |
| Q4 2025 | 4.22M | $7.55M | Hold |
| Q1 2026 | 4.22M | $8.22M | Hold |
| Q2 2026 | 4.22M | $7.17M | Hold |
| Q3 2026 | 4.22M | $2.51M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NMRA and 13F data
NMRA (NEUMORA THERAPEUTICS INC.) is a Health Care company. 17 other funds we track also report a position in NMRA — the largest reported positions include SOFTBANK GROUP CORP. (US$10.4M), MIC Capital Management UK LLP (US$7.6M), ICONIQ Capital, LLC (US$4.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NMRA
- SOFTBANK GROUP CORP. 6.09M sh · $10.35M · Q2 2026
- MIC Capital Management UK LLP 4.46M sh · $7.58M · Q2 2026
- ICONIQ Capital, LLC 2.56M sh · $4.35M · Q2 2026
- Boxer Capital Management, LLC 2.00M sh · $3.40M · Q2 2026
- WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST 3.31M sh · $1.97M · Q3 2026
FAQ
How long has Exor N.V. held NMRA?
Exor N.V. has disclosed NMRA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Exor N.V.'s current position in NMRA?
As of Q3 2026, Exor N.V. holds 4.22M shares of NMRA (NEUMORA THERAPEUTICS INC.), valued at $2.51M, representing 0.01% of its reported portfolio and ranking #7.
Has Exor N.V. been buying or selling NMRA?
In the latest 13F filing (Q3 2026), Exor N.V. held unchanged its position in NMRA. The position peaked in Q4 2023 at 4.22M shares.
Which other funds hold NMRA?
Other major institutional holders of NMRA include SOFTBANK GROUP CORP., MIC Capital Management UK LLP, ICONIQ Capital, LLC, among 17 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.